BQR695
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 206861

CAS#: 1513879-21-4

Description: BQR695, also known as BQR695 NVP-BQR695, is a potent and selective PI4K inhibitor.


Price and Availability

Size
Price

100mg
USD 850
1g
USD 3650
Size
Price

200mg
USD 1250
2g
USD 4850
Size
Price

500mg
USD 2450
5g
USD 8450

NVP-BQR695, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 206861
Name: BQR695
CAS#: 1513879-21-4
Chemical Formula: C19H20N4O3
Exact Mass: 352.1535
Molecular Weight: 352.394
Elemental Analysis: C, 64.76; H, 5.72; N, 15.90; O, 13.62


Synonym: NVP-BQR695; NVP-BQR-695; NVP-BQR 695; BQR695; BQR-695; BQR 695.

IUPAC/Chemical Name: 2-((7-(3,4-dimethoxyphenyl)quinoxalin-2-yl)amino)-N-methylacetamide

InChi Key: LYPCULYCGFOIDA-UHFFFAOYSA-N

InChi Code: InChI=1S/C19H20N4O3/c1-20-19(24)11-22-18-10-21-14-6-4-12(8-15(14)23-18)13-5-7-16(25-2)17(9-13)26-3/h4-10H,11H2,1-3H3,(H,20,24)(H,22,23)

SMILES Code: O=C(NC)CNC1=NC2=CC(C3=CC=C(OC)C(OC)=C3)=CC=C2N=C1


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: Fowler ML, McPhail JA, Jenkins ML, Masson GR, Rutaganira FU, Shokat KM,
Williams RL, Burke JE. Using hydrogen deuterium exchange mass spectrometry to
engineer optimized constructs for crystallization of protein complexes: Case
study of PI4KIIIβ with Rab11. Protein Sci. 2016 Apr;25(4):826-39. doi:
10.1002/pro.2879. Epub 2016 Feb 1. PubMed PMID: 26756197; PubMed Central PMCID:
PMC4832280.